概括
阿帕明是一种蜂毒神经毒素,阻断了平滑肌肉中ATP诱导的通道活性. 这一发现表明,阿巴胺不是一种特定的ATP受体阻断剂,而是抑制的透性变化.
科学领域:
- 神经药理学神经药理学
- 顺滑肌肉生理学 顺滑肌肉生理学
- 蜜蜂毒研究研究 蜜蜂毒研究
背景情况:
- 亚胺是一种来自蜜蜂毒的神经毒性多,具有已知的结构.
- 以前的研究表明,ATP是非上腺抑制神经供给内脏光滑肌的神经递质.
- 亚胺被暂时确定为这种纯能抑制的特定后突触阻断剂.
研究的目的:
- 为了研究阿帕明对内脏光滑肌肉的作用机制.
- 为了确定阿帕明是否作为ATP介导抑制的特定后突触阻断剂.
- 为了澄清阿帕明在非上腺激素,纯激素抑制中的作用.
主要方法:
- 实验证实了阿帕明对ATP的影响和神经刺激诱导的抑制.
- 研究阿帕明对透性的影响.
- 在内脏光滑肌肉制剂 (海豚胃和大肠杆菌) 中使用的纳米度的阿巴明.
主要成果:
- 亚胺在纳米分子度下通过外部应用的ATP和非上腺神经刺激减少了抑制.
- 发现阿帕明可以抑制由ATP诱导的透率的增加.
- 结果表明,阿帕明的作用并不特定于ATP受体.
结论:
- 亚胺抑制了由ATP和其他物质引起的透率的增加.
- 亚巴胺不是ATP受体的特定后突触阻断剂.
- 阿帕明对的透性的更广泛的影响是其对非上腺体,纯能平滑肌肉抑制的抑制作用的基础.
更多相关视频
相关概念视频
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...


